Clorox (NYSE:CLX) Given New $159.00 Price Target at The Goldman Sachs Group

Clorox (NYSE:CLX) had its price target lifted by The Goldman Sachs Group from $141.00 to $159.00 in a research note published on Tuesday morning, Analyst Ratings Network reports. The brokerage currently has a sell rating on the stock.

A number of other equities analysts have also commented on CLX. JPMorgan Chase & Co. lowered shares of Clorox from a neutral rating to an underweight rating and lowered their price target for the stock from $171.00 to $147.00 in a research report on Tuesday, November 2nd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $156.00 to $160.00 and gave the stock a hold rating in a research report on Tuesday, November 2nd. Wells Fargo & Company raised their price target on shares of Clorox from $155.00 to $159.00 and gave the stock an underweight rating in a research report on Tuesday, November 2nd. Morgan Stanley lowered their price target on shares of Clorox from $160.00 to $154.00 and set an underweight rating on the stock in a research report on Wednesday, October 13th. Finally, Barclays reduced their price objective on shares of Clorox from $138.00 to $131.00 and set an underweight rating on the stock in a research note on Wednesday, November 3rd. Seven equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of Hold and a consensus price target of $170.41.

Shares of CLX opened at $186.60 on Tuesday. The firm has a market capitalization of $22.93 billion, a PE ratio of 53.93, a PEG ratio of 4.76 and a beta of 0.21. The company’s 50-day moving average is $171.51 and its 200-day moving average is $170.33. Clorox has a fifty-two week low of $156.23 and a fifty-two week high of $231.11. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.69 and a quick ratio of 0.39.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Sunday, October 31st. The company reported $1.21 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.03 by $0.18. Clorox had a net margin of 6.04% and a return on equity of 84.70%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.70 billion. During the same period in the prior year, the firm earned $3.22 earnings per share. The company’s revenue was down 5.7% on a year-over-year basis. Analysts predict that Clorox will post 5.46 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 11th. Stockholders of record on Wednesday, January 26th will be paid a $1.16 dividend. The ex-dividend date is Tuesday, January 25th. This represents a $4.64 dividend on an annualized basis and a dividend yield of 2.49%. Clorox’s payout ratio is currently 134.10%.

In related news, SVP Diego J. Barral sold 240 shares of Clorox stock in a transaction that occurred on Tuesday, November 16th. The shares were sold at an average price of $170.00, for a total transaction of $40,800.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.58% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of the stock. Marshall Wace North America L.P. bought a new position in Clorox during the 1st quarter worth approximately $65,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in Clorox by 12.6% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,245 shares of the company’s stock worth $4,182,000 after purchasing an additional 2,598 shares during the last quarter. Rockefeller Capital Management L.P. raised its holdings in Clorox by 15.9% during the 2nd quarter. Rockefeller Capital Management L.P. now owns 15,194 shares of the company’s stock worth $2,732,000 after purchasing an additional 2,088 shares during the last quarter. Citigroup Inc. raised its holdings in Clorox by 4.8% during the 2nd quarter. Citigroup Inc. now owns 306,145 shares of the company’s stock worth $55,079,000 after purchasing an additional 14,092 shares during the last quarter. Finally, Atria Investments LLC raised its holdings in Clorox by 20.5% during the 2nd quarter. Atria Investments LLC now owns 13,843 shares of the company’s stock worth $2,490,000 after purchasing an additional 2,353 shares during the last quarter. Institutional investors and hedge funds own 76.81% of the company’s stock.

About Clorox

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

Featured Story: What is the Gross Domestic Product (GDP)?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.